Morgan Stanley
PROK icon

Morgan Stanley’s ProKidney PROK Stock Holding History

Morgan Stanley’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.4M Sell
9,850,142
-4,036
-0% -$6.81K ﹤0.01% 3270
2026
Q2 		$20.1M Buy
9,854,178
+898,211
+10% +$1.64M ﹤0.01% 3092
2026
Q1 		$16M Buy
8,955,967
+138,966
+2% +$295K ﹤0.01% 3163
2025
Q4 		$19.8M Buy
8,817,001
+2,069,979
+31% +$5.44M ﹤0.01% 2945
2025
Q3 		$16.3M Buy
6,747,022
+759,481
+13% +$2.02M ﹤0.01% 3075
2025
Q2 		$3.55M Sell
5,987,541
-4,349,682
-42% -$3.39M ﹤0.01% 4338
2025
Q1 		$9.06M Sell
10,337,223
-3,636,134
-26% -$5.05M ﹤0.01% 3430
2024
Q4 		$23.6M Sell
13,973,357
-297,028
-2% -$535K ﹤0.01% 2595
2024
Q3 		$27.4M Sell
14,270,385
-177,956
-1% -$404K ﹤0.01% 2473
2024
Q2 		$35.5M Buy
14,448,341
+4,121,663
+40% +$11.1M ﹤0.01% 2072
2024
Q1 		$16.9M Sell
10,326,678
-870,521
-8% -$1.28M ﹤0.01% 2873
2023
Q4 		$19.9M Buy
11,197,199
+910,833
+9% +$1.95M ﹤0.01% 2692
2023
Q3 		$47.1M Buy
10,286,366
+590,964
+6% +$5.66M ﹤0.01% 1637
2023
Q2 		$108M Buy
9,695,402
+84,317
+0.9% +$897K 0.01% 1038
2023
Q1 		$109M Sell
9,611,085
-1,336,410
-12% -$14.2M 0.01% 1010
2022
Q4 		$75.1M Buy
10,947,495
+595,839
+6% +$5.69M 0.01% 1210
2022
Q3 		$93.3M Buy
+10,351,656
New +$90.1M 0.01% 930
2022
Q1 		– Sell
-9,456
Closed -$94K – 8081
2021
Q4 		$94K Buy
9,456
+2,600
+38% +$25.7K ﹤0.01% 6484
2021
Q3 		$67K Buy
+6,856
New +$67.5K ﹤0.01% 6584

Other funds holding PROK

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Propel Bio Management
Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return
Bleichroeder LP
Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Brown University
Brown University Providence, Rhode Island $147M AUM 5.01% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Morgan Stanley's PROK Position: Q3 2026 in Review

Morgan Stanley reduced its ProKidney (PROK) stake by 0.04% in Q3 2026, selling an estimated $6.81K and leaving 9,850,142 shares worth $16.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3270.

Morgan Stanley first reported a position in PROK in Q3 2021 and has held it in 19 quarters since. The position peaked at $109M in Q1 2023. 67 funds tracked by Wall St. Rank hold PROK as of Q3 2026.

  • Morgan Stanley held 9,850,142 shares of ProKidney worth $16.4M as of Q3 2026.
  • Morgan Stanley sold 4,036 ProKidney shares in Q3 2026, an estimated $6.81K.
  • ProKidney made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #3270 holding.
  • Morgan Stanley first reported a position in ProKidney in Q3 2021 and has held it in 19 quarters since.
  • Morgan Stanley's ProKidney position peaked at $109M in Q1 2023.
  • 67 funds tracked by Wall St. Rank held ProKidney as of Q3 2026.

Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.